[go: up one dir, main page]

AUPQ077199A0 - A method using potassium dihydrogen phosphate to reduce calcification of tissue - Google Patents

A method using potassium dihydrogen phosphate to reduce calcification of tissue

Info

Publication number
AUPQ077199A0
AUPQ077199A0 AUPQ0771A AUPQ077199A AUPQ077199A0 AU PQ077199 A0 AUPQ077199 A0 AU PQ077199A0 AU PQ0771 A AUPQ0771 A AU PQ0771A AU PQ077199 A AUPQ077199 A AU PQ077199A AU PQ077199 A0 AUPQ077199 A0 AU PQ077199A0
Authority
AU
Australia
Prior art keywords
tissue
dihydrogen phosphate
potassium dihydrogen
reduce calcification
calcification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ0771A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FREMANTLE HEART INSTITUTE Pty Ltd
Original Assignee
FREMANTLE HEART INST Pty Ltd
METROPOLITAN HEALTH SERVICE BO
Neethling W M L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FREMANTLE HEART INST Pty Ltd, METROPOLITAN HEALTH SERVICE BO, Neethling W M L filed Critical FREMANTLE HEART INST Pty Ltd
Priority to AUPQ0771A priority Critical patent/AUPQ077199A0/en
Publication of AUPQ077199A0 publication Critical patent/AUPQ077199A0/en
Priority to AU49009/00A priority patent/AU773150B2/en
Priority to PCT/AU2000/000633 priority patent/WO2000074692A1/en
Assigned to FREMANTLE HEART INSTITUTE PTY LTD, HODGE, ANDREW JULIAN, NEETHLING, WILLIAM MORRIS LEONARD reassignment FREMANTLE HEART INSTITUTE PTY LTD Change of Name of Applicant under S 104 Assignors: FREMANTLE HEART INSTITUTE PTY LTD, Hodge, Andrew Julien, METROPOLITAN HEALTH SERVICE BOARD, NEETHLING, WILLIAM MORRIS LEONARD
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3625—Vascular tissue, e.g. heart valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/02—Treatment of implants to prevent calcification or mineralisation in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials For Medical Uses (AREA)
AUPQ0771A 1999-06-03 1999-06-03 A method using potassium dihydrogen phosphate to reduce calcification of tissue Abandoned AUPQ077199A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPQ0771A AUPQ077199A0 (en) 1999-06-03 1999-06-03 A method using potassium dihydrogen phosphate to reduce calcification of tissue
AU49009/00A AU773150B2 (en) 1999-06-03 2000-06-02 A method using potassium dihydrogen phosphate to reduce calcification of tissue
PCT/AU2000/000633 WO2000074692A1 (en) 1999-06-03 2000-06-02 A method using potassium dihydrogen phosphate to reduce calcification of tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ0771A AUPQ077199A0 (en) 1999-06-03 1999-06-03 A method using potassium dihydrogen phosphate to reduce calcification of tissue

Publications (1)

Publication Number Publication Date
AUPQ077199A0 true AUPQ077199A0 (en) 1999-06-24

Family

ID=3814968

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ0771A Abandoned AUPQ077199A0 (en) 1999-06-03 1999-06-03 A method using potassium dihydrogen phosphate to reduce calcification of tissue

Country Status (2)

Country Link
AU (1) AUPQ077199A0 (en)
WO (1) WO2000074692A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109833517B (en) * 2018-09-27 2019-11-12 四川大学 A cross-linking treatment method for improving the stability of biological valve elastin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813465A (en) * 1971-12-16 1974-05-28 I Lerner Cytological preservative and mucolytic composition
CA1340181C (en) * 1987-02-19 1998-12-15 Health Care Products, Inc. Sanitized, sterilized, disinfected and sporicidal articles and processesfor sanitizing, sterilizing, disinfecting and rendering objects sporicidal and improved sanitizing, sterilizing, and disinfecting composition
JPH0662417B2 (en) * 1987-12-25 1994-08-17 参天製薬株式会社 Anti-allergic eye drops
ATE218802T1 (en) * 1993-08-12 2002-06-15 Univ North Carolina FLUSHING SOLUTION FOR ORGANS AND TISSUES
DE19834087C1 (en) * 1998-07-29 2000-03-30 Mirzaie Sedaposhteh Massoud Aqueous preservative solution for storage of animal tissue, especially porcine heart valves, contains sodium, potassium, magnesium and calcium salts, glucose and chelate former

Also Published As

Publication number Publication date
WO2000074692A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
AU6372900A (en) Linkage of agents to tissue
AU1449401A (en) Method using prior activities to improve the completion of transaction
AU6373000A (en) Lysine oxidase linkage of agents to tissue
AU2001287144A1 (en) Fixation band for affixing a prosthetic heart valve to tissue
AU3863199A (en) Two piece prosthetic heart valve
AU3920900A (en) Compounds and methods to treat cardiac failure and other disorders
AU5311500A (en) Implantable joint prosthesis
AU1068800A (en) Prosthetic heart valve
PL350828A1 (en) Method of making a disposable wiper-cloth
AU3104999A (en) Catheter for delivery of energy to a surgical site
AU2289900A (en) Press fit connection between prosthetic components of joint prostheses
AU7870900A (en) Treatment of scar tissue using lipoic acid
AU3077299A (en) Method of promoting production of living tissue equivalents
AU3213200A (en) Inhibitors of intestinal apical membrane na/phosphate co-transportation
AU6686400A (en) Emg control of prosthesis
AU5913198A (en) A method and composition for cancer treatment by enzymatic conversion of solubleradioactive toxic agents
AU6078500A (en) Combination therapy for conditions leading to bone loss
AU2583200A (en) Heart valve prosthesis
AU7345400A (en) A method of treatment of human immunodeficiency diseases
AU3938299A (en) Method of altering heartbeat
AU2781899A (en) Use of a cardiac purinoceptor to effect cellular glucose uptake
AU1183101A (en) Method relating to anodic bonding
AU4414999A (en) Inhibition of delta-9-desaturase activity by saponins
AUPQ077199A0 (en) A method using potassium dihydrogen phosphate to reduce calcification of tissue
AU5765700A (en) Preparation of a therapeutic composition

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 4900900

Country of ref document: AU